EC
Eric Coldwell Baird Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Fortrea Holdings
FTRE
$954M
| $10.51 | $14 |
33%
upside
| Outperform | 2 days ago |
|
2 |
2
Icon
ICLR
$13.7B
| $176.36 | $224 |
27%
upside
| Outperform | 2 days ago |
|
3 |
3
Quest Diagnostics
DGX
$20.1B
| $180.11 | $194 |
8%
upside
| Neutral | 10 days ago |
|
4 |
4
Premier
PINC
$2.17B
| $26.28 | $27 |
3%
upside
| Neutral | 16 days ago |
|
5 |
5
Cardinal Health
CAH
$35.7B
| $149.34 | $203 |
36%
upside
| Outperform | 23 days ago |
|
6 |
6
Owens & Minor
OMI
$417M
| $5.40 | $7 |
30%
upside
| Outperform | 24 days ago |
|
7 |
7
Labcorp
LH
$22.9B
| $275.23 | $302 |
10%
upside
| Outperform | 1 month ago |
|
8 |
8
Medpace
MEDP
$13.6B
| $482.34 | $490 |
2%
upside
| Neutral | 1 month ago |
|
9 |
9
IQVIA
IQV
$31.3B
| $184.08 | $196 |
6%
upside
| Neutral | 1 month ago |
|
10 |
10
Charles River Laboratories
CRL
$7.99B
| $162.31 | $140 |
14%
downside
| Neutral | 4 months ago |
|
11 |
11
AdaptHealth
AHCO
$1.25B
| $9.21 | $16 |
74%
upside
| Outperform | 6 months ago |
|
12 |
12
McKesson
MCK
$86B
| $691.45 | $688 |
1%
downside
| Outperform | 10 months ago |
|
13 |
13
H.B. Fuller
FUL
$3.31B
| $61.29 | $45 |
27%
downside
| Neutral | 5 years ago |
|
14 |
14
CVS Health
CVS
$93.5B
| $73.69 | $66 |
10%
downside
| Neutral | 5 years ago |
|